INOVIO to Report Second Quarter Financial Results on August 12, 2026

INOVIO (NASDAQ: INO) will release its second quarter 2026 financial results after the market close on August 12, 2026.

Rhea-AI Summary

INOVIO (NASDAQ: INO) will release its second quarter 2026 financial results after the market close on August 12, 2026. The company will host a live, listen-only conference call and webcast at 4:30 p.m. ET to review the results and provide a general business update. The webcast, including a live Q&A with analysts, will be accessible via INOVIO's investor relations website and will remain available as an archived replay for 90 days.

Argus Aug 5 session 1 alert

+2.10% close to close 0.6x rel. volume Open Argus

Details

News Market Reaction – INO

$74.90M Mkt Cap at Peak Alert

On Aug 5, the first trading day after this news, INO closed 2.10% above the previous close.

Data tracked by StockTitan Argus for the Aug 5 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its second quarter 2026 financial results will be released after the market close on August 12th, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will INOVIO (NASDAQ: INO) report its Q2 2026 financial results?

INOVIO will report its second quarter 2026 financial results on August 12, 2026, after the market close. According to INOVIO, the release will be followed by a conference call and webcast at 4:30 p.m. ET.

What time is INOVIO's Q2 2026 earnings conference call on August 12, 2026?

INOVIO's Q2 2026 conference call and webcast will begin at 4:30 p.m. ET on August 12, 2026. According to INOVIO, the event will discuss financial results and provide a general business update.

How can investors access the INOVIO (INO) Q2 2026 earnings webcast?

Investors can access INOVIO's Q2 2026 webcast at http://ir.inovio.com/events-and-presentations/default.aspx. According to INOVIO, this listen-only webcast will stream the conference call and include a live Q&A with analysts.

Will there be a replay of INOVIO's Q2 2026 earnings call for INO shareholders?

Yes, a replay of INOVIO's Q2 2026 earnings webcast will be available for 90 days. According to INOVIO, the archived webcast can be accessed through the company's investor relations events and presentations webpage.

Is INOVIO's Q2 2026 earnings conference call a listen-only event for the public?

Yes, INOVIO’s Q2 2026 earnings conference call is a listen-only event for the public. According to INOVIO, the webcast will still feature a live Q&A session with analysts.